General characteristics
The underlying cause of all porphyrias is a defective enzyme
somewhere along the heme biosynthesis pathway. In virtually all
cases, the defective enzyme is a genetically linked factor.
Therefore, porphyrias are inheritable conditions. However, an
environmental trigger--such as diet, drugs, or sun exposure--may be
necessary before any symptoms develop. In many cases, symptoms do
not develop, and people may be completely unaware that they have a
gene for porphyria.
All of the hepatic porphyrias--except porphyria cutanea tarda--follow
a pattern of acute attacks interspersed among periods of complete
symptom remission. For this reason, they are often referred to as
the acute porphyrias. The erythropoietic porphyrias and porphyria
cutanea tarda do not follow the same pattern and are considered
chronic conditions.
The specific symptoms of each porphyria depend on the affected
enzyme and whether it occurs in the liver or in the bone marrow. The
severity of symptoms can vary widely, even within the same porphyria
type. If the porphyria becomes symptomatic, the common factor
between all types is an abnormal accumulation of protoporphyrins or
porphyrin.
ALA dehydratase porphyria (ADP)
ADP is characterized by a deficiency of ALA dehydratase. Of the few
cases on record, the prominent symptoms were vomiting, pain in the
abdomen, arms, and legs, and neuropathy. (Neuropathy refers to nerve
damage that can cause pain, numbness, or paralysis.) Owing to the
neuropathy, the arms and legs may be weak or paralyzed and breathing
can be impaired.
Acute intermittent porphyria (AIP)
AIP is caused by a deficiency in porphobilogen deaminase, but
symptoms usually don't occur unless a person with the deficiency
encounters a trigger substance. Such substances can include hormones
(for example oral contraceptives, menstruation, pregnancy), drugs,
and dietary factors. However, most people with the deficiency never
develop symptoms.
Attacks occur after puberty and commonly feature severe abdominal
pain, nausea and vomiting, and constipation. Muscle weakness and
pain in the back, arms, and legs are also typical symptoms. During
an attack, the urine takes on a deep reddish color. The central
nervous system may also be involved, as demonstrated by
hallucinations, confusion, seizures, and mood changes.
Congenital erythropoietic porphyria (CEP)
CEP arises from a deficiency in uroporphyrinogen III cosynthase.
Symptoms are often apparent in infancy and include reddish urine and
possibly an enlarged spleen. The skin is unusually sensitive to
light and blisters easily if exposed to sunlight. (Sunlight induces
changes in protoporphyrins in the plasma and skin. These altered
molecules can damage the skin.) Increased hair growth is common.
Damage from recurrent blistering and associated skin infections can
be severe; in some cases facial features and fingers are lost to
recurrent damage and infection. Deposits of protoporphyrins
sometimes occur in the teeth and bones.
Porphyria cutanea tarda (PCT)
PCT is caused by deficient uroporphyrinogen decarboxylase; it may be
an acquired or inherited condition. The acquired form usually does
not appear until adulthood. The inherited form may appear in
childhood, but often demonstrates no symptoms. Early symptoms
include blistering on the hands, face, and arms following minor
injuries or exposure to sunlight. Lightening or darkening of the
skin may occur along with increased hair growth or loss of hair.
Liver function is abnormal but the signs are mild.
Hepatoerythopoietic porphyria (HEP)
HEP is linked to a deficiency of uroporphyrinogen decarboxylase in
both the liver and the bone marrow. The symptoms resemble those of
CEP.
Hereditary coproporphyria (HCP)
HCP is similar to AIP, but the symptoms are typically more mild; the
disorder is caused by a deficiency in coproporphyrinogen oxidase.
The greatest difference between HCP and AIP is that people with HCP
may have some skin sensitivity to sunlight. However, extensive
damage to the skin is rarely seen.
Variegate porphyria (VP)
VP is caused by deficient protoporphyrinogen oxidase, and, like AIP,
symptoms only occur during attacks. Major symptoms of this type of
porphyria involve neurologic problems and sensitivity to light.
Areas of the skin that are exposed to sunlight are susceptible to
burning, blistering, and scarring.
Erythropoietic protoporphyria (EPP)
Owing to deficient ferrochelatase, the last step in the heme
biosynthesis pathway--the insertion of an iron atom into a porphyrin
molecule--cannot be completed. The major symptoms of this disorder
are related to sensitivity to light--including both artificial and
natural light sources. Following exposure to light, a person with
EPP experiences burning, itching, swelling, and reddening of the
skin. Blistering and scarring may occur but are neither common nor
severe. EPP may result in the formation of gallstones as well as
liver complications. Symptoms can appear in childhood and tend to be
more severe during the summer when exposure to sunlight is more
likely. |